PHARMACY

MinuteClinic offers free A1c tests in line with American Diabetes Month

BY Antoinette Alexander

WOONSOCKET, R.I. In recognition of American Diabetes Month in November, MinuteClinic is offering complimentary A1c tests beginning Oct. 25 through Nov. 25, CVS Caremark has announced. The free tests, sponsored by Bayer Diabetes Care, are available while supplies last.

"Our goal is to provide convenient locations where the more than 24 million Americans with diabetes can walk in and see a practitioner to receive advice and basic testing to help them better monitor their condition," stated Andrew Sussman, president of MinuteClinic and SVP/associate chief medical officer of CVS Caremark. "The A1c test is the best measure available to assess a diabetic patient’s immediate condition and determine whether any changes in treatment and lifestyle habits are needed. With more than 1.6 million new diabetics diagnosed each year, the need for providing more accessible options to help patients monitor their condition is critical."

As part of the complimentary A1c test, MinuteClinic practitioners will check a patient’s vital signs, review medical history and administer the blood test. Results are available within five minutes and are discussed with the patient. A visit summary that includes the A1c test results is made available to primary care providers with patient permission. Visit summaries typically are sent within 24 hours via electronic medical record, fax or mail.

In addition to daily self-testing of glucose levels, diabetics should receive regular A1c tests that measure their average blood glucose levels over a two- to three-month period, the company stated. The American Diabetes Association advised that patients keep their A1c level below 7%.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

‘Picture This’ forums bring diabetes management awareness to public

BY Allison Cerra

PRINCETON, N.J. A few days after it released a report on how awareness and education play an integral role in the prevention, detection and treatment of diabetes, Novo Nordisk is bringing it to the public.

The drug maker said Friday that, through its collaboration with the Entertainment Industries Council, it will host "Picture This" forums, which include an open discussion among diabetes stakeholders and the media to identify top diabetes communication challenges, explore strategies to address those priorities and strengthen community understanding about diabetes through news media and community affairs programs.

The forums will be held in Philadelphia on Oct. 22 and Seattle on Nov. 18.

 

"Novo Nordisk is proud to join EIC, the media and community leaders in Seattle and Philadelphia to explore ways to improve how diabetes is communicated about and understood by local citizens," said Tony Deluzio, senior medical director at Novo Nordisk. "As the prevalence of diabetes continues to be on the rise, bringing together those on the front line of diabetes care will open the potential to reduce the stigma associated with diabetes and empower those affected by the disease to lead full and productive lives."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Pfizer makes official tender offer for King

BY Alaric DeArment

NEW YORK Pfizer officially has made its tender offer to buy King Pharmaceuticals for $3.6 billion, or $14.25 per share, Pfizer said Friday.

 

The offer constitutes a 40% premium over the closing price of King’s stock on Oct. 11, when Pfizer originally made the offer. King, based in Bristol, Tenn., specializes in pain medications designed to deter misuse and abuse, and Pfizer said the acquisition would enhance its position in the pain-relief market.

 

 

The offer expires at midnight on Nov. 19.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES